Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-κB p65

Por Shimada, Hideaki, Rajagopalan, Lakshman E.
Publicado em 2010

Employment of gene expression profiling to identify transcriptional regulators of hepatic stellate cells

Por Shimada, Hideaki, Rajagopalan, Lakshman E
Publicado em 2012

Neck Dissection for Thoracic Esophageal Squamous Cell Carcinoma

Por Yajima, Satoshi, Oshima, Yoko, Shimada, Hideaki
Publicado em 2012

A Potential Therapeutic Strategy for Malignant Mesothelioma with Gene Medicine

Por Tada, Yuji, Shimada, Hideaki, Hiroshima, Kenzo, Tagawa, Masatoshi
Publicado em 2013

Activation of potassium conductance by ophiopogonin-D in acutely dissociated rat paratracheal neurones

Por Ishibashi, Hitoshi, Mochidome, Takanobu, Okai, Junpei, Ichiki, Hiroyuki, Shimada, Hideaki, Takahama, Kazuo
Publicado em 2001

Gene medicine for cancer treatment: Commercially available medicine and accumulated clinical data in China

Por Ma, Guangyu, Shimada, Hideaki, Hiroshima, Kenzo, Tada, Yuji, Suzuki, Nobuo, Tagawa, Masatoshi
Publicado em 2009

A Possible Anticancer Agent, Type III Interferon, Activates Cell Death Pathways and Produces Antitumor Effects

Por Tagawa, Masatoshi, Kawamura, Kiyoko, Li, Quanhai, Tada, Yuji, Hiroshima, Kenzo, Shimada, Hideaki
Publicado em 2011

Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy

Por Matsushita, Kazuyuki, Shimada, Hideaki, Ueda, Yasuji, Inoue, Makoto, Hasegawa, Mamoru, Tomonaga, Takeshi, Matsubara, Hisahiro, Nomura, Fumio
Publicado em 2014

Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin

Por Ak, Guntulu, Tada, Yuji, Shimada, Hideaki, Metintas, Selma, Ito, Masaaki, Hiroshima, Kenzo, Tagawa, Masatoshi, Metintas, Muzaffer
Publicado no BMC Cancer (2017)

Adhesion molecule periplakin is involved in cellular movement and attachment in pharyngeal squamous cancer cells

Por Tonoike, Yurie, Matsushita, Kazuyuki, Tomonaga, Takeshi, Katada, Koji, Tanaka, Nobuko, Shimada, Hideaki, Nakatani, Yukio, Okamoto, Yoshitaka, Nomura, Fumio
Publicado em 2011

Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma

Por Nomura Fumio, Kuboshima Mari, Kagaya Akiko, Yasuraoka Mari, Shiratori Tooru, Shimada Hideaki, Takiguchi Masaki, Ochiai Takenori, Matsubara Hisahiro, Hiwasa Takaki
Publicado em 2009-07-01

Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma

Por Shimada, Hideaki, Shiratori, Tooru, Yasuraoka, Mari, Kagaya, Akiko, Kuboshima, Mari, Nomura, Fumio, Takiguchi, Masaki, Ochiai, Takenori, Matsubara, Hisahiro, Hiwasa, Takaki
Publicado em 2009

Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway

Por Rahmutulla, Bahityar, Matsushita, Kazuyuki, Satoh, Mamoru, Seimiya, Masanori, Tsuchida, Sachio, Kubo, Shuji, Shimada, Hideaki, Ohtsuka, Masayuki, Miyazaki, Masaru, Nomura, Fumio
Publicado em 2013

Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carci...

Por Suzuki, Takeo, Kawamura, Kiyoko, Li, Quanhai, Okamoto, Shinya, Tada, Yuji, Tatsumi, Koichiro, Shimada, Hideaki, Hiroshima, Kenzo, Yamaguchi, Naoto, Tagawa, Masatoshi
Publicado em 2014

Gene Therapy of c-myc Suppressor FUSE-Binding Protein-Interacting Repressor by Sendai Virus Delivery Prevents Tracheal Stenosis

Por Mizokami, Daisuke, Araki, Koji, Tanaka, Nobuaki, Suzuki, Hiroshi, Tomifuji, Masayuki, Yamashita, Taku, Ueda, Yasuji, Shimada, Hideaki, Matsushita, Kazuyuki, Shiotani, Akihiro
Publicado no PLoS One (2015)

A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene

Por Tada, Yuji, Hiroshima, Kenzo, Shimada, Hideaki, Morishita, Naoya, Shirakawa, Toshiro, Matsumoto, Kunio, Shingyoji, Masato, Sekine, Ikuo, Tatsumi, Koichiro, Tagawa, Masatoshi
Publicado no Springerplus (2015)

An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol

Por Tada, Yuji, Hiroshima, Kenzo, Shimada, Hideaki, Shingyoji, Masato, Suzuki, Toshio, Umezawa, Hiroki, Sekine, Ikuo, Takiguchi, Yuichi, Tatsumi, Koichiro, Tagawa, Masatoshi
Publicado no Springerplus (2016)

Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways

Por Shimazu, Kengo, Tada, Yuji, Morinaga, Takao, Shingyoji, Masato, Sekine, Ikuo, Shimada, Hideaki, Hiroshima, Kenzo, Namiki, Takao, Tatsumi, Koichiro, Tagawa, Masatoshi
Publicado no BMC Cancer (2017)

Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma

Por Jiang, Yuanyuan, Zhong, Boya, Kawamura, Kiyoko, Morinaga, Takao, Shingyoji, Masato, Sekine, Ikuo, Tada, Yuji, Tatsumi, Koichiro, Shimada, Hideaki, Hiroshima, Kenzo, Tagawa, Masatoshi
Publicado no BMC Cancer (2016)

Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels

Por Okamoto, Shinya, Jiang, Yuanyuan, Kawamura, Kiyoko, Shingyoji, Masato, Fukamachi, Toshihiko, Tada, Yuji, Takiguchi, Yuichi, Tatsumi, Koichiro, Shimada, Hideaki, Hiroshima, Kenzo, Kobayashi, Hiroshi, Tagawa, Masatoshi
Publicado em 2013